D, Z., Y, W., J, L., G, Z., E, C., & N, W. (2025). Targeting YES1 enhances the efficacy of chemotherapy, targeted therapy and onco-immunotherapy. Cellular signalling, 136, 112108. https://doi.org/10.1016/j.cellsig.2025.112108
Παραπομπή σε μορφή Chicago (17η εκδ.)D, Zheng, Wang Y, Li J, Zhang G, Chu E, και Wei N. "Targeting YES1 Enhances the Efficacy of Chemotherapy, Targeted Therapy and Onco-immunotherapy." Cellular Signalling 136 (2025): 112108. https://doi.org/10.1016/j.cellsig.2025.112108.
Παραπομπή σε μορφή MLA (9th εκδ.)D, Zheng, et al. "Targeting YES1 Enhances the Efficacy of Chemotherapy, Targeted Therapy and Onco-immunotherapy." Cellular Signalling, vol. 136, 2025, p. 112108, https://doi.org/10.1016/j.cellsig.2025.112108.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.